Eagle Pharmaceuticals

$47.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.81 (+1.74%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell EGRX and other stocks, options, and ETFs commission-free!

About EGRX

Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ. The listed name for EGRX is Eagle Pharmaceuticals, Inc. Common Stock.

CEO
Scott L. Tarriff
Employees
108
Headquarters
Woodcliff Lake, New Jersey
Founded
2007
Market Cap
616.45M
Price-Earnings Ratio
133.49
Dividend Yield
Average Volume
93.65K
High Today
$47.48
Low Today
$46.26
Open Price
$46.27
Volume
65.29K
52 Week High
$62.41
52 Week Low
$33.80

Collections

EGRX Earnings

$0.00
$0.39
$0.78
$1.17
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, Pre-Market

You May Also Like